Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Joe

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Genetic Epidemiology|April 11, 2003
Exploring the "two-hit hypothesis" in NF2: tests of two-hit and three-hit models of vestibular schwannoma developmentRyan Woods, J M Friedman, D Gareth R Evans, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 1, 2011
Empirical development of improved diagnostic criteria for neurofibromatosis 2Michael E Baser, Jan M Friedman, Harry Joe, et al.
American Journal of Human Genetics|September 18, 2002
Predictors of the risk of mortality in neurofibromatosis 2Michael E Baser, J M Friedman, Dana Aeschliman, et al.
American Journal of Human Genetics|June 11, 2004
Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based studyMichael E Baser, Lisa Kuramoto, Harry Joe, et al.
Journal of Medical Genetics|August 16, 2015
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patientsAdam Hexter, Adrian Jones, Harry Joe, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Genetic Epidemiology|April 11, 2003
Exploring the "two-hit hypothesis" in NF2: tests of two-hit and three-hit models of vestibular schwannoma developmentRyan Woods, J M Friedman, D Gareth R Evans, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 1, 2011
Empirical development of improved diagnostic criteria for neurofibromatosis 2Michael E Baser, Jan M Friedman, Harry Joe, et al.
American Journal of Human Genetics|September 18, 2002
Predictors of the risk of mortality in neurofibromatosis 2Michael E Baser, J M Friedman, Dana Aeschliman, et al.
American Journal of Human Genetics|June 11, 2004
Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based studyMichael E Baser, Lisa Kuramoto, Harry Joe, et al.
Journal of Medical Genetics|August 16, 2015
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patientsAdam Hexter, Adrian Jones, Harry Joe, et al.
Pageof 2